https://www.selleckchem.com/Androgen-Receptor.html
Patients with systemic lupus erythematosus (SLE) are usually treated with glucocorticosteroids even during periods of clinically quiescent disease. A recent study showed that abrupt glucocorticoid withdrawal was associated with an increased likelihood of flare in the next 12 months. The aim of the present study was to assess clinical flare rates and damage accrual in patients who tapered glucocorticosteroids gradually. Patients from the Toronto Lupus Clinic with 2 consecutive years of clinically quiescent disease were retrieved from th
Like
Comment
Share
